Instrument Inactif

Communiqués Spring Bank Pharmaceuticals, Inc.

Actions

SBPH

US8494311017

Communiqués

25/11/20	F-STAR THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
24/11/20	Spring Bank Pharmaceuticals : F-star Therapeutics Announces Approval of Clinical Trial Application for FS222	PU
22/11/20	Spring Bank Pharmaceuticals : F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals	PU
22/11/20	Spring Bank Pharmaceuticals : F-star Therapeutics to Present New Clinical and Mechanistic Data on its LAG-3/PD-L1 Tetravalent Bispecific Antibody, FS118, at the SITC 2020 Virtual Annual Meeting	PU
20/11/20	F-STAR THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Registrant's Certifying Accountant, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20/11/20	Spring Bank Pharmaceuticals : Stockholders Approve Combination with F-star Therapeutics	AQ
19/11/20	Spring Bank Pharmaceuticals : Stockholders Approve Combination with F-star Therapeutics	AQ
19/11/20	Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics	GL
09/11/20	SPRING BANK PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
06/11/20	Spring Bank Pharmaceuticals : Announces Special Dividend of Contingent Value Rights	AQ
06/11/20	Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights	GL
03/11/20	SPRING BANK PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
03/11/20	Spring Bank Pharmaceuticals : Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer Annual Meeting	AQ
02/11/20	Spring Bank Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting	GL
02/11/20	Spring Bank Pharmaceuticals : Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting	AQ
10/08/20	SPRING BANK PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
10/08/20	Spring Bank Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Results	GL
03/08/20	SPRING BANK ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SBPH and Encourages Investors to Contact the Firm	BU
31/07/20	SPRING BANK PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
30/07/20	SPRING BANK PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
29/07/20	Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies	GL
25/06/20	SPRING BANK PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
03/06/20	Spring Bank Advances IV SB 11285 Clinical Program	GL
26/05/20	Spring Bank to Present at the Jefferies Virtual Global Healthcare Conference	GL
21/05/20	Spring Bank Pharmaceuticals : Announces Poster Presentation at the 2020 American Society of Clinical Oncology Virtual Annual Meeting	AQ